rg1507
Showing 1 - 9 of 9
Non-Squamous NSCLC Trial in Worldwide (Placebo, RG1507, erlotinib [Tarceva])
Terminated
- Non-Squamous Non-Small Cell Lung Cancer
- Placebo
- +2 more
-
Beverly Hills, California
- +56 more
Dec 5, 2020
Tumors Trial in United States (RG1507)
Completed
- Neoplasms
- RG1507
-
Tucson, Arizona
- +5 more
Oct 29, 2016
Tumors Trial in Aurora, New Brunswick, Houston (RG1507)
Completed
- Neoplasms
- RG1507
-
Aurora, Colorado
- +2 more
Nov 1, 2016
Breast Cancer Trial in Edinburgh (RG1507)
Completed
- Breast Cancer
- RG1507
-
Edinburgh, United Kingdom(unnamed)
Nov 1, 2016
Tumors Trial in United States (RG1507, RO1507, bevacizumab [Avastin])
Terminated
- Neoplasms
- RG1507
- +16 more
-
Tucson, Arizona
- +7 more
Nov 1, 2016
NSCLC Trial in Worldwide (RG1507, erlotinib [Tarceva])
Terminated
- Non-Small Cell Lung Cancer
- RG1507
- erlotinib [Tarceva]
-
Santa Monica, California
- +15 more
Jun 19, 2013